Search Results - aditya+mohan

1 Results

Sort By:

A DNAJB1-PRKACA fusion kinase peptide vaccine for patients with fibrolamellar hepatocellular carcinoma

Unmet NeedFibrolamellar carcinoma (FLC) is an extremely rare form of cancer. It affects both men and women in approximately 1 in 5,000,000 people with greater frequency among young adults with a median age of diagnosis of 25. Unfortunately, there is no standard of care therapy for this cancer, and patients with this disease have an expected median survival...

Published: 9/27/2024 | Inventor(s): Mark Yarchoan, Elizabeth Jaffee, Aditya Mohan

Keywords(s):

Category(s): Clinical and Disease Specializations > Oncology > Liver Cancer, Technology Classifications > Therapeutic Modalities > Vaccines, Technology Classifications > Therapeutic Modalities > Immunotherapies